The latest report published by IMARC Group, titled “Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on the global protein therapeutics market growth. The report also includes competitor and regional analysis, and contemporary advancements in the market. The market size reached US$ 322.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 487.0 Billion by 2028, exhibiting a growth rate (CAGR) of 7% during 2023-2028.

Industry Definition and Application:

Protein therapeutics refers to a class of pharmaceutical drugs that are based on proteins or peptides. These therapeutic agents are designed to target specific proteins, pathways, or receptors within the body to treat or manage various diseases and medical conditions. Protein therapeutics have high specificity, potency, and the ability to modulate biological processes effectively. Protein therapeutics are typically derived from naturally occurring proteins or engineered through biotechnological processes. They can be classified into several categories based on their mechanism of action, including cytokines, monoclonal antibodies, enzymes, hormones, and growth factors. Cytokines are protein-based therapeutics that regulate cell signaling and immune responses. They can be used to enhance the immune system’s response to infections or cancers or to suppress an overactive immune response in autoimmune diseases. Monoclonal antibodies (mAbs) are one of the most well-known classes of protein therapeutics. They are designed to recognize and bind to specific antigens, such as cancer cells or disease-causing pathogens, thereby modulating immune responses and promoting targeted therapy.

Enzymes, such as replacement enzymes, are used to replace deficient or dysfunctional enzymes in patients with enzyme deficiencies or metabolic disorders. These enzymes help restore normal biochemical pathways and alleviate disease symptoms. Hormones and growth factors, such as insulin and erythropoietin, are protein therapeutics used to regulate various physiological processes. They can be employed to manage hormone deficiencies or stimulate specific cellular activities. Protein therapeutics offer targeted and personalized approaches to treatment, often with reduced side effects as compared to traditional small-molecule drugs. The development of protein therapeutics involves rigorous research, protein engineering, and manufacturing processes. Proteins are typically produced through recombinant DNA technology, where the desired gene sequence is inserted into host cells, such as bacteria or mammalian cells, to produce the protein of interest. Extensive purification and quality control measures ensure the safety, efficacy, and purity of the final protein therapeutic product.

Request to Get the Sample Report: https://www.imarcgroup.com/protein-therapeutics-market/requestsample

What are the growth prospects and trends in the industry?

The increasing prevalence of chronic and age-related diseases, such as cancer, autoimmune disorders, diabetes, and cardiovascular diseases, represents a key factor driving the global protein therapeutics market growth across the globe. The market is also driven by rapid advancements in the field of biotechnology, including recombinant DNA technology and protein engineering techniques, which have facilitated the development of more sophisticated and effective protein therapeutics.

The rising shift toward personalized medicine, driven by advances in genomic research and precision medicine approaches is contributing to the growth of the market. In addition to this, the widespread adoption of biologics as a preferred treatment option, particularly for complex diseases, is further facilitating the growth of the market. Other factors, including the rising investment in research and development (R&D) activities related to protein therapeutics, favorable regulatory environment providing clear guidelines and efficient approval processes, rapid development and commercialization of protein-based drugs, and the increasing healthcare expenditure, are creating a positive outlook for the market across the globe.

Competitive Landscape With Key Players:

The competitive landscape of the protein therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Amgen Inc.

  • Abbott Laboratories

  • Abbvie Inc.

  • Baxter International Inc.

  • Biogen Inc.

  • Csl Behring L.L.C. (CSL Limited)

  • Eli Lilly and Company

  • F. Hoffmann-La Roche AG (Roche Holding AG)

  • Johnson & Johnson

  • Merck & Co. Inc.

  • Novo Nordisk A/S (Novo Holdings A/S)

  • Pfizer Inc.

Key Market Segmentation:

The report has segmented the global protein therapeutics market based on product, therapy area, function and region.

Breakup by Product:

  • Monoclonal Antibodies (mAbs)

  • Human Insulin

  • Erythropoietin

  • Clotting Factors

  • Fusion Protein

  • Others

Breakup by Therapy Area:

  • Metabolic Disorders

  • Immunological Disorders

  • Hematological Disorders

  • Cancer

  • Hormonal Disorders

  • Genetic Disorders

  • Others

Breakup by Function:

  • Enzymatic and Regulatory Activity

  • Special Targeting Activity

  • Vaccines

  • Protein Diagnostics

Breakup by Region:

  • North America

  • Asia Pacific

  • Europe

  • Latin America

  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2431&flag=C

Key Highlights of the Report:

  • Market Performance (2017-2022)

  • Market Outlook (2023-2028)

  • Market Trends

  • Market Drivers and Success Factors

  • Impact of COVID-19

  • Value Chain Analysis

  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800